Secondary pharmaceutical patenting: A global perspective
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Lanjouw, Jean O & Pakes, Ariel & Putnam, Jonathan, 1998. "How to Count Patents and Value Intellectual Property: The Uses of Patent Renewal and Application Data," Journal of Industrial Economics, Wiley Blackwell, vol. 46(4), pages 405-432, December.
- Mark A. Lemley & Bhaven Sampat, 2012. "Examiner Characteristics and Patent Office Outcomes," The Review of Economics and Statistics, MIT Press, vol. 94(3), pages 817-827, August.
- Sampat, Bhaven N. & Shadlen, Kenneth C., 2015. "Drug patenting in India: looking back andlooking forward," LSE Research Online Documents on Economics 62652, London School of Economics and Political Science, LSE Library.
- Sternitzke, Christian, 2010. "Knowledge sources, patent protection, and commercialization of pharmaceutical innovations," Research Policy, Elsevier, vol. 39(6), pages 810-821, July.
- María José Abud Sittler & Bronwyn Hall & Christian Helmers, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," NBER Working Papers 20995, National Bureau of Economic Research, Inc.
- Yamauchi, Isamu & Nagaoka, Sadao, 2015. "An economic analysis of deferred examination system: Evidence from a policy reform in Japan," International Journal of Industrial Organization, Elsevier, vol. 39(C), pages 19-28.
- Gaétan de Rassenfosse & Adam B. Jaffe & Elizabeth Webster, 2016. "Low-quality Patents in the Eye of the Beholder: Evidence from Multiple Examiners," NBER Working Papers 22244, National Bureau of Economic Research, Inc.
- Kenneth C. Shadlen, 2011. "The Political Contradictions of Incremental Innovation: Lessons from Pharmaceutical Patent Examination in Brazil," Politics & Society, , vol. 39(2), pages 143-174, June.
- Elizabeth Webster & Paul H. Jensen & Alfons Palangkaraya, 2014. "Patent examination outcomes and the national treatment principle," RAND Journal of Economics, RAND Corporation, vol. 45(2), pages 449-469, June.
- Carlos Correa, 2007. "Guidelines for the Examination of Pharmaceutical Patents: Developing a Public Health Perspective," Working Papers id:1203, eSocialSciences.
More about this item
KeywordsPharmaceuticals; Patents; TRIPS; Developing countries; Patent quality; Patent examination;
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:respol:v:46:y:2017:i:3:p:693-707. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dana Niculescu). General contact details of provider: http://www.elsevier.com/locate/respol .